1,2-Ethanediamine,N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyrimidinyl-, hydrochloride(1:1) cas no:63-56-9
Synonyms: 1,2-Ethanediamine,N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyrimidinyl-, monohydrochloride(9CI); Pyrimidine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-,hydrochloride (7CI); Pyrimidine,2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-, monohydrochloride (8CI);2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyrimidine hydrochloride;Anahist; N,N-Dimethyl-N'-(p-methoxybenzyl)-N'-(2-pyrimidyl)ethylenediaminehydrochloride; N-p-Methoxybenzyl-N',N'-dimethyl-N-2-pyrimidinylethylene diaminehydrochloride; NH 188; Neohetramine hydrochloride; Resistab; Super Anahist;Thonzylamine hydrochloride; Thonzylaminium chloride; Tonamil
Name1,2-Ethanediamine,N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyrimidinyl-, hydrochloride(1:1)
CAS63-56-9
Synonyms1,2-Ethanediamine,N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyrimidinyl-, monohydrochloride(9CI); Pyrimidine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-,hydrochloride (7CI); Pyrimidine,2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-, monohydrochloride (8CI);2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyrimidine hydrochloride;Anahist; N,N-Dimethyl-N'-(p-methoxybenzyl)-N'-(2-pyrimidyl)ethylenediaminehydrochloride; N-p-Methoxybenzyl-N',N'-dimethyl-N-2-pyrimidinylethylene diaminehydrochloride; NH 188; Neohetramine hydrochloride; Resistab; Super Anahist;Thonzylamine hydrochloride; Thonzylaminium chloride; Tonamil
EINECS(EC#)200-561-3
Molecular FormulaC16H22 N4 O . Cl H
Molecular Weight286.37208
Appearancewhite crystalline powder
Safety
Poison by ingestion, intravenous, and intraperitoneal routes. Used as an antihistamine. When heated to decomposition it emits very toxic fumes of HCl and NOx.
| 1. |
|
orl-mus LD50:245 mg/kg
|
|
NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),536. |
| 2. |
|
ipr-mus LD50:110 mg/kg
|
|
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 123 (1960),419. |
| 3. |
|
orl-gpg LD50:493 mg/kg
|
|
NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),536. |
| 4. |
|
ivn-gpg LD50:38,200 µg/kg
|
|
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 113 (1958),313. |